Global and China Biomedicine Market 2012-2020: Market Size, Structure, Trends, Analysis and Forecast
Grace Market Data |
SKU : 92000010
Pages : 118 | Aug, 15 | Region : Global
Figures : NULL | Tables : NULL
Category: Pharma & Healthcare
The annual growth rate of world biomedicine market has been outpacing that of the overall pharmaceutical market in recent years and this trend will continue in the coming years with a steady 10.4% growth per annum by 2020. In particular, China’s biomedicine market is expected to grow at an even higher rate (15% annually) over the forecast 2015-2020 period, driven by increasing and aging population, government initiatives and favorable policies, improving level of biotech and innovation, and increasing urbanization as well as household income in China.
Global and China Biomedicine Market 2012-2020: Market Size, Structure, Trends, Analysis and Forecast reviews the worldwide market of biological medicines and reagents with Chinese biomedicine market examined in detail specifically. With global economic, demographic, and healthcare profiles reviewed as market environments, this report provides market trend of world biomedicines for 2012-2020, market structure of product segments (Therapeutic Protein, Antibody, Vaccines, Blood Products, and Diagnostic Reagent), dynamics of biosimilar segment, geographic spread (North America, Europe, Asia Pacific region, Latin America and the rest of world), development highlights in global biomedicines market, and 20 profiled leading biomedicine manufacturers in the world.
Qualitative market analyses for Chinese biomedicine market include market growth drivers, restraints and challenges, emerging market opportunities, and competitive landscape. Based on biomedicine type, China’s biomedicine market is segmented into Therapeutic Protein, Antibody, Vaccines, Blood Products, and Diagnostic Reagent, with the fast-growing generic biomedicines highlighted in particular. The nation’s market is also analyzed by marketing channel and by region. The historic performance and benchmarked outlook for China’s biomedicine imports, exports, and manufacturing industry are also provided with data available for 2010-2020 period. The major biological bases and clusters in China are revealed and 32 Chinese key biomedicine producers are profiled.
Figure 1. Recent Growth Trend of World Gross Product, 2008–2016
Figure 2. Global Population Estimates by Age, 2000-2050 (millions)
Figure 3. Global Population Estimates by Age, 2000-2050 (%)
Figure 4. Regional Distribution of the Global Population of People 65 and Older, 2010 and 2050, %
Figure 5. Total Health Expenditure as a Percentage of GDP for Major Economies (2013)
Figure 6. Global Biomedicine Market and Growth Rate, 2012-2020
Figure 7. Trend of Global Biosimilar Sales and Its Share in Biomedicine Market, 2012-2020
Figure 8. Geographic Distribution of Global Biomedicine Market by Region, 2014, $bn
Figure 9. Geographic Distribution of Global Biomedicine Market by Region, 2020, $bn
Figure 10. A Typical Value Chain in Biomedical R&D Pipeline
Figure 11. China Biomedicine Market Trend and Share in the Global Market, 2012-2020
Figure 12. China Therapeutic Protein Market and Share, 2012-2020, $bn
Figure 13. China Antibody Market and Share, 2012-2020, $bn
Figure 14. China Vaccine Market and Share, 2012-2020, $bn
Figure 15. China Blood Products Market and Share, 2012-2020, $bn
Figure 16. China Diagnostic Reagent Market and Share, 2012-2020, $bn
Figure 17. Sales Share of China’s Biomedicines by Marketing Channel, 2012-2020
Figure 18. Export Value of China’s Biomedicines and Overall Pharmaceuticals, 2010-2020
Figure 19. Import Value of China’s Biomedicines and Overall Pharmaceuticals, 2010-2020
Table 1. Overview of World and China’s Biomedicine Market, 2012-2020, $ bn
Table 2. Average Annual Growth Rates of Global Real GDP, Outlook to 2030, %
Table 3. Population Estimates, by Region, 2010 and 2050 (millions)
Table 4. Per Capita Total Expenditure on Health at Average Exchange Rate by Country 2003-2012 (US$)
Table 5. World Biomedicine Market by Sub-Product, 2012-2020, $ bn
Table 6. World Top 20 Biomedicine Manufacturers in 2014, $bn
Table 7. Geographic Spread of China Biomedicine Market by Profit, 2014
Table 8. Output Value of China’s Pharmaceutical and Biomedicine Manufacture Industry, 2010-2020, $ bn
Table 9. China Top Biomedicine Companies by Revenue, 2013Q1-Q3, RMB million
|Single User License||Hard Copy||Site License||Global License|
|Users/ Sharing||Restricted to 10 Authorized Users||Unlimited within the Geography||Unlimited within the Geography||Unlimited within any geography|
|Printing/Copy||Unlimited within Company / Enterprise||Unlimited within Company / Enterprise|
|10% Pre-sale customization|
|16 Hours post sales support|
|Free report on update within 100 days from purchase date|
Bonafide Research & Marketing shall grant the user a worldwide, non-exclusive, non-transferable license. User can opt for -
Single User License (Electronic):Access to the content will be granted to 10 authorized users within the organization. The Authorized User may store, display or archive the information but is not allowed to print, copy or use any information in the report for circulation or citation purpose. The individual user will treat the information in the report as confidential and will only use this for internal purpose. The report will be emailed to you in PDF format.
Enterprise wide (Hard Copy):Access to the content will be granted to all authorized users within the organization. The individual user will treat the information in the report as confidential and will only use this for internal purpose. Please add $250 when purchasing the Report in order to get the printed version.
Site License (Electronic):Access to the content will be granted to all the authorised within the organization. The users are authorized to store, display, duplicate, archive the information within the organization either electronically or printable files. The users are not authorized to use any information in the report for citation and circulation externally. The users will treat the information in the report as confidential and will only use this for internal purpose.
Enterprise Wide License (Electronic):The report will be emailed to you in PDF format and hard copy format. This is an enterprise license, allowing all employees within your organization access to the product. The company can use the data / information externally but they need to mention source as Bonafide Research
Whether a single user or a multi user, you are not permitted to -
Every project that comes through our doors gets senior-level attention at every step of the way. Our insights drive intelligent and informed decision-making and this is why our clients come back to us when it's time for the next project.
Outlook and Overview Reports!!
Simplified Pricing Strategy:
Discounts & benefits!!!